NIH Gathers for Research Grants: Business as Usual
Published Date: 5/6/2025
Notice
Summary
The National Institutes of Health (NIH) is holding a hybrid meeting on May 29, 2025, where they’ll discuss important health research updates and review grant applications. This meeting affects researchers and organizations applying for NIH funding, with some parts open to the public and others private to protect sensitive info. If you want to watch or share your thoughts, there’s a chance to join online or send comments before the meeting.
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
Public can watch and comment
You can watch the NIH Council of Councils meeting on May 29, 2025 via the NIH Videocasting website. Any interested person may also file written comments with the committee before the meeting by sending a statement with your name, address, phone number, and affiliation to the listed contact person.
Grant reviews closed to protect confidentiality
The Council will close the meeting from 12:15 p.m. to 01:15 p.m. on May 29, 2025 to review grant applications. That closed session is to protect confidential trade secrets, patentable material, and personal information about applicants.
Accommodations available for virtual viewers
If you plan to view the virtual meeting on May 29, 2025 and need special assistance or other reasonable accommodations, you should notify the contact person listed in advance (Franziska Grieder, phone 301-435-0744, email provided).
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14966, Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a new Ebola vaccine invention for companies to license and develop quickly. This vaccine targets the Bundibugyo virus and promises fast and lasting protection, helping stop outbreaks in Central Africa. Businesses interested in licensing should act soon to bring this life-saving tech to market and can contact NIH for details.
Previous / Next Documents
Previous: 2025-07816, Franklin Lexington Private Markets Fund, et al.
Franklin Lexington and its partners want permission to team up and invest together in certain companies, even though current rules usually say no. This change affects several investment funds and could help them work smarter and share opportunities. If no one objects by May 27, 2025, the SEC will likely approve this move, potentially impacting how these funds manage their money.
Next: 2025-07818, National Institute on Deafness and Other Communication Disorders; Notice of Closed Meeting
The National Institute on Deafness and Other Communication Disorders is holding a private meeting on November 3-4, 2025, to review the skills and work of its researchers. This meeting affects scientists working on hearing and communication research and helps ensure top-quality projects continue. No public attendance or funding changes are involved, but the review keeps research sharp and effective.